Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPennon Regulatory News (PNN)

Share Price Information for Pennon (PNN)

Share Price is delayed by 15 minutes
Get Live Data
514.00    1.00 (0.19%)
Bid:
514.00
Ask:
515.00
Spread: 1.00 (0.195%)
Market Cap: £2.43b
PNN Live PriceLast checked at - London Stock Exchange

Intraday Pennon Share Chart

Pennon Group CEO Transition Arrangements

9 Dec 2025 07:00

RNS Number : 7327K
Pennon Group PLC
09 December 2025
 

PENNON GROUP PLC

9 December 2025

 

Pennon Group CEO Transition Arrangements

 

Further to the announcement on 11 July 2025 regarding Susan Davy's retirement from the Board of Pennon Group and as Chief Executive Officer, the Board confirms that Susan will step down from the Board on the 31 December 2025.

To support an orderly succession, the Board has approved interim arrangements covering the period between Susan stepping down from the Board and Keith Haslett joining the Board, following his notice period, which will be no later than 30 June 2026.

From 1 January 2026, David Sproul, Chair of Pennon Group, will assume the role of Executive Chair, supported by an Operating Committee with delegated executive authority to run the business and continue delivery of the Group's strategy.

The Operating Committee comprises:

· Laura Flowerdew, Group Chief Financial Officer

 

· Sarah Heald, Group Chief Strategy, Regulatory Affairs & Investor Relations Officer

 

· Andrew Garard, Group General Counsel and Company Secretary

During this period, Susan will remain available to provide handover support to ensure a smooth transition and continuity until Keith's arrival.

Susan Davy said "My brilliant colleagues are firmly focused on delivery of our five-year plan, having made a robust start to the regulatory period. Our half year results confirm we are on track financially and operationally, delivering for customers, communities and the environment. I will continue to be available to support the team during this transition ahead of Keith's arrival."

David Sproul said "I would like to reiterate the Board's thanks to Susan for her unwavering leadership. We announced Keith's appointment in September, our succession planning enables a smooth and orderly transition, ahead of him joining Pennon Group as CEO following his notice period. With the support of the Board and the Operating Committee, I will ensure that Pennon Group continues on a business-as-usual basis."

For further information, please contact:

Pennon Group plc

 

Sarah Heald

Chief Strategy, Regulatory Affairs and Investor Relations Officer

+44 (0)1392 443 364

Katy Ringsdore

 

FGS Global

Director of External Communications

James Murgatroyd

Michael Turner

+44(0)20 7251 3801

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOADBBDDDBGDGUI
Date   Source Headline
1st Jun 20267:00 amRNSTotal Voting Rights
29th May 20262:06 pmRNSHolding(s) in Company
20th May 20261:48 pmRNSDirector/PDMR Shareholding
14th May 202612:03 pmRNSDirector/PDMR Shareholding
6th May 20262:12 pmRNSAdmission to Trading
1st May 20264:31 pmRNSHolding(s) in Company
1st May 20267:00 amRNSTotal Voting Rights
30th Apr 20263:11 pmRNSHolding(s) in Company
27th Apr 20264:34 pmRNSHolding(s) in Company
24th Apr 20263:29 pmRNSHolding(s) in Company
22nd Apr 20264:30 pmRNSHolding(s) in Company
21st Apr 20261:17 pmRNSDirector/PDMR Shareholding
20th Apr 20264:09 pmRNSHolding(s) in Company
14th Apr 20264:24 pmRNSRescheduled Full-Year Results Date
1st Apr 20267:00 amRNSTotal Voting Rights
20th Mar 20262:06 pmRNSDirector/PDMR Shareholding
10th Mar 20267:00 amRNSTrading Statement
2nd Mar 20267:00 amRNSTotal Voting Rights
23rd Feb 202612:58 pmRNSDirector/PDMR Shareholding
10th Feb 20267:00 amRNSConfirmation of Chief Executive Officer Start Date
5th Feb 202610:58 amRNSHolding(s) in Company
2nd Feb 20267:01 amRNSTotal Voting Rights
2nd Feb 20267:00 amRNSBlock listing Interim Review
23rd Jan 20263:21 pmRNSDirector/PDMR Shareholding
2nd Jan 20267:00 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTotal Voting Rights
23rd Dec 20253:29 pmRNSDirector/PDMR Shareholding
23rd Dec 20253:29 pmRNSDirector/PDMR Shareholding
11th Dec 20251:16 pmRNSConfirmed Financial Calendar
9th Dec 20254:01 pmRNSDirector/PDMR Shareholding
9th Dec 20257:00 amRNSPennon Group CEO Transition Arrangements
1st Dec 20253:42 pmRNSEMTN: Publication of Supplementary Prospectus
1st Dec 20257:00 amRNSTotal Voting Rights
27th Nov 20257:00 amRNSHalf Year Results 2025/26
21st Nov 20254:24 pmRNSDirector/PDMR Shareholding
3rd Nov 20257:00 amRNSTotal Voting Rights
22nd Oct 20251:26 pmRNSDirector/PDMR Shareholding
7th Oct 20257:00 amRNSPennon appoints new Non-Executive Director
3rd Oct 20252:19 pmRNSDirector/PDMR Shareholding
2nd Oct 20257:00 amRNSPennon Group appoints Keith Haslett as new CEO
1st Oct 20257:00 amRNSTotal Voting Rights
26th Sep 20257:00 amRNSTrading Statement
23rd Sep 20254:16 pmRNSDirector/PDMR Shareholding
11th Sep 202512:09 pmRNSEMTN Programme: Publication of Final Terms
1st Sep 20257:00 amRNSTotal Voting Rights
28th Aug 20252:44 pmRNSDirector/PDMR Shareholding
22nd Aug 20259:41 amRNSEMTN Programme: Publication of Base Prospectus
20th Aug 20254:15 pmRNSDirector/PDMR Shareholding
1st Aug 20257:01 amRNSTotal Voting Rights
1st Aug 20257:00 amRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.